US AI In MRI Market - Strategic Insights and Forecasts (2026-2031)

The US AI in MRI Market is projected to grow at a CAGR of 18.2%, reaching USD 895.4 million by 2031 from USD 388.6 million in 2026, driven by rising imaging demand and workflow automation needs.

FDA 510(k) clearances validate the safety and clinical utility of AI-powered MRI software, removing regulatory barriers and accelerating commercial adoption by hospitals and diagnostic centers.

The market is structurally shifting toward software and services, as AI-driven image acceleration, automated measurements, and reporting tools deliver measurable gains in patient throughput and interpretation speed.

Unclear Medicare reimbursement for AI-augmented MRI procedures remains a key constraint. The creation of new CPT/HCPCS codes and the proposed Clinically Meaningful Algorithmic Analyses (CMAA) framework are critical for large-scale adoption.

Key trends include AI-enabled triage systems, accelerated image acquisition, cloud-based deployments, and reimbursement policy evolution, all aimed at improving turnaround time and patient safety.